Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study.
aerosol drug therapy
hemodynamics
prostanoid
pulmonary hypertension
right ventricular function
Journal
Pulmonary circulation
ISSN: 2045-8932
Titre abrégé: Pulm Circ
Pays: United States
ID NLM: 101557243
Informations de publication
Date de publication:
Historique:
received:
15
03
2019
accepted:
15
08
2019
entrez:
8
10
2019
pubmed:
8
10
2019
medline:
8
10
2019
Statut:
epublish
Résumé
The Breelib™ nebulizer was designed to reduce iloprost inhalation times for patients with pulmonary arterial hypertension (PAH). In 30 patients with PAH, rapid inhalation of iloprost 2.5 µg using Breelib™ caused significant improvements in invasively measured afterload and cardiac index but not echocardiographic right ventricular strain during 30 min post-inhalation.
Identifiants
pubmed: 31588353
doi: 10.1177/2045894019875342
pii: 10.1177_2045894019875342
pmc: PMC6740066
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2045894019875342Informations de copyright
© The Author(s) 2019.
Références
Pulm Circ. 2018 Oct-Dec;8(4):2045894018798921
pubmed: 30124140
Pulm Circ. 2017 Apr-Jun;7(2):505-513
pubmed: 28597762
Vasc Health Risk Manag. 2009;5(1):465-74
pubmed: 19475782
Eur Respir J. 2017 Aug 24;50(2):
pubmed: 28838981
Pulm Circ. 2018 Oct-Dec;8(4):2045894018781537
pubmed: 29781778
Eur Respir J. 2008 Apr;31(4):891-901
pubmed: 18378784
JACC Cardiovasc Imaging. 2019 Mar 13;:null
pubmed: 30878422
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Pulm Circ. 2015 Mar;5(1):162-70
pubmed: 25992279
N Engl J Med. 2002 Aug 1;347(5):322-9
pubmed: 12151469
Am J Respir Crit Care Med. 2019 Jun 1;199(11):e41-e42
pubmed: 30645142